Aducanumab: The Drug That Breaks Medicare?
Biogen plans to price-gouge for the barely-effective Alzheimer’s drug aducanumab to such a degree that it could bust Medicare.
Read more...Biogen plans to price-gouge for the barely-effective Alzheimer’s drug aducanumab to such a degree that it could bust Medicare.
Read more...Trying to understand America’s self-and-other-destructive empire fetish.
Read more...Private equity is doing yet more damage to heath care as it buys up primary care practices en masse.
Read more...Even Biden loyalists are getting nervous.
Read more...Feds weigh in on Purdue bankruptcy plan, raising possibility that Sacklers won’t get off more or less scot-free for their role in the opioids crisis.
Read more...How Haiti is a fiefdom for gangs and foreigners pilfering the country’s natural resources.
Read more...The funding for shale production in the US has dried up as moneybags finally realize that there’s no profit to be had.
Read more...The trauma center ripoff provides more evidence that the medical industry is primarily in the business of exploitation, not care.
Read more...Biden goes after non-compete agreements….but will this effort make a difference?
Read more...The latest Robinhood campaign is more raspberry than rah rah.
Read more...Cleveland Clinic’s and the CDC Foundation’s unsound Clorox sponsorship confirms that the US has the best medical system that money can buy.
Read more...Why mindfulness practices don’t move seamlessly across cultures.
Read more...Michael Hudson gives another wide-ranging, tour de force interview. Enjoy!
Read more...Last week, President Joe Biden and Apple co-founder Steve Wozniak endorsed the right to repair.
Read more...Those pesky lawyers behind Mayberry v. KKR won’t give up! And some private equity titans are likely plenty unhappy about that.
Read more...